JOHN KIRKWOOD to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.480
-
Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin Oncol. 2008 Feb 01; 26(4):527-34.
Score: 0.296
-
IFN-a in the treatment of melanoma. J Immunol. 2012 Oct 15; 189(8):3789-93.
Score: 0.103
-
Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials. J Clin Oncol. 2000 Nov 15; 18(22):3782-93.
Score: 0.045
-
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma. J Clin Oncol. 2017 Dec 01; 35(34):3815-3822.
Score: 0.036